{"id":479,"count":0,"description":"
\r\n View current Docunment Here<\/a>\r\n View New Docunment Here<\/a>\r\n <\/div>\r\n
\r\n

Ordering IG In Ontario - Changes coming! <\/h2>\r\n

WHY: <\/h3>

The use of Immunoglobulin (Ig) products, specifically Intravenous Immunoglobulin (IVIg) and Subcutaneous Immunoglobulin (SCIg), continues to increase each year, at an average rate of 8-9%.<\/p>\r\n

In 2020, the Office of the Auditor General of Ontario (OAGO) released the findings of their Value-for-Money Audit of Blood Management and Safety (https:\/\/www.auditor.on.ca\/en\/content\/annualreports\/arreports\/en20\/20VFM_02bloodmgmt.pdf<\/a>). <\/p>\r\n

Recommendation three specifically stated the need: <\/p> \r\n

\u201cTo better manage the demand and supply of immunoglobulins so that they are available for Ontarians who need them most and to avoid costs of wasted product, we recommend that the MOH, in consultation with Ontario Health: Collect more complete data from hospitals on how immunoglobulins are being used and identify emerging conditions that may warrant inclusion in provincial utilization guidelines\u2026...\u201d.<\/i><\/b><\/p>\r\n

Currently in Ontario, Ig requests are completed by the prescriber and sent to Transfusion Medicine Laboratories on paper requisitions (MOH IG Request Forms- Neurology and Non-Neurology<\/a>). These paper forms do not leave the hospital transfusion laboratory in which they are submitted. Lack of provincial Ig utilization data makes it difficult to understand how Ig is being used. <\/p>\r\n